Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC).

Bergmeijer, Thomas O

Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC). [electronic resource] - American heart journal 04 2018 - 152-159 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1097-6744

10.1016/j.ahj.2017.12.010 doi


Aged
Female
Humans
Male
Middle Aged
Acute Coronary Syndrome--diagnosis
Clopidogrel--therapeutic use
Genetic Association Studies
Genome-Wide Association Study
Internationality
Molecular Targeted Therapy--methods
Pharmacogenetics
Prognosis
Receptors, Purinergic P2Y12--drug effects
Risk Assessment
Survival Rate
Treatment Outcome